Claims for Patent: 4,948,807

Summary for Patent: 4,948,807

Title:	Phenyl carbamates
Abstract:	Phenyl carbamates of the general formula ##STR1## wherein R.sub.1 to R.sub.5 are as defined in the claims, are useful as pharmaceuticals.
Inventor(s):	Rosin; Marta W. (Jerusalem, IL), Chorev; Michael (Jerusalem, IL), Tashma; Zeev (Jerusalem, IL)
Assignee:	Proterra AG (Zug, CH)
Application Number:	07/320,700
Patent Claims:	1. N-cyclohexyl-3-[1-(dimethylamino)ethyl]phenyl carbamate and pharmacologically acceptable salts thereof. 2. N-allyl-3-[1-(dimethylamino)ethyl]phenyl carbamate and pharmacologically acceptable salts thereof. 3. N-ethyl, N-methyl-3-[1-(dimethylamino)ethyl]phenyl carbamate and pharmacologically acceptable salts thereof. 4. A method of treating a subject suffering from senile dementia, Alzhemier's disease, Huntingdon's chorea, tardive dyskinesias,, hyperkinesia, mania, acute confusion disorders, Friedrich's ataxia and Down's syndrome, which comprises administering to such a subject a therapeutically effective amount of a compound selected from the group consisting of N-cyclohexyl-3-[1-(dimethylamino)ethyl]phenyl carbamate, N-allyl-3-[1-(dimethylamino)ethyl]phenyl carbamate, N-ethyl, N-methyl-3[1-(dimethylamino)ethyl]phenyl carbamate, and pharmacologically acceptable salts thereof.